Literature DB >> 29070965

Validity and Reliability of Four Clinical Gait Measures in Patients with Multiple Sclerosis.

Susan E Bennett, Lacey E Bromley, Nadine M Fisher, Machiko R Tomita, Paulette Niewczyk.   

Abstract

BACKGROUND: The gold standards for assessing ambulation are the Expanded Disability Status Scale (EDSS) and the Timed 25-Foot Walk (T25FW) test. In relation with these measures, we assessed the reliability and validity of four clinical gait measures: the Timed Up and Go (TUG) test, the Dynamic Gait Index (DGI), the 2-Minute Walk Test (2MWT), and the 6-Minute Walk Test (6MWT). Patient self-report of gait was also assessed using the 12-item Multiple Sclerosis Walking Scale (MSWS-12).
METHODS: Individuals 20 years or older with a diagnosis of multiple sclerosis (MS) and an EDSS score of 2.0 to 6.5 completed the MSWS-12, T25FW test, TUG test, DGI, 2MWT, and 6MWT. All the tests were repeated 2 weeks later at the same time of day to establish their reliability and concurrent validity. Predictive validity was established using the EDSS.
RESULTS: Forty-two patients with MS were included. All measures showed high test-retest reliability. The TUG test, 2MWT, and 6MWT were significantly correlated with the T25FW test (Spearman ρ = -0.902, -0.919, and -0.905, respectively). The EDSS was also significantly correlated with all the walking tests. The MSWS-12 demonstrated the highest correlation to the EDSS (ρ = 0.788).
CONCLUSIONS: The TUG test, the DGI, the 2MWT, and the 6MWT exhibited strong psychometric properties and were found to be significant predictors of the EDSS score. Use of these tests to prospectively monitor the effects of medical and rehabilitation treatment should be considered in the comprehensive care of patients with MS.

Entities:  

Year:  2017        PMID: 29070965      PMCID: PMC5649348          DOI: 10.7224/1537-2073.2015-006

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  28 in total

1.  MS functional composite: relation to disease phenotype and disability strata.

Authors:  N F Kalkers; V de Groot; R H Lazeron; J Killestein; H J Adèr; F Barkhof; G J Lankhorst; C H Polman
Journal:  Neurology       Date:  2000-03-28       Impact factor: 9.910

2.  Comparison of the 2-, 6-, and 12-minute walk tests in patients with stroke.

Authors:  Marc Kosak; Teresa Smith
Journal:  J Rehabil Res Dev       Date:  2005 Jan-Feb

3.  Disease activity free status: a new end point for a new era in multiple sclerosis clinical research?

Authors:  Carolyn J Bevan; Bruce A C Cree
Journal:  JAMA Neurol       Date:  2014-03       Impact factor: 18.302

Review 4.  Clinimetric properties of the Timed Up and Go Test for patients with stroke: a systematic review.

Authors:  Thóra B Hafsteinsdóttir; Marijke Rensink; Marieke Schuurmans
Journal:  Top Stroke Rehabil       Date:  2014 May-Jun       Impact factor: 2.119

5.  Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses.

Authors:  Aseel Bin Sawad; Enrique Seoane-Vazquez; Rosa Rodriguez-Monguio; Fatema Turkistani
Journal:  Curr Med Res Opin       Date:  2016-09-07       Impact factor: 2.580

6.  Ambulatory activity in individuals with multiple sclerosis.

Authors:  James T Cavanaugh; Victor O Gappmaier; Leland E Dibble; Eduard Gappmaier
Journal:  J Neurol Phys Ther       Date:  2011-03       Impact factor: 3.649

7.  Reliability of the Dynamic Gait Index in individuals with multiple sclerosis.

Authors:  Jennifer McConvey; Susan E Bennett
Journal:  Arch Phys Med Rehabil       Date:  2005-01       Impact factor: 3.966

Review 8.  Treatment optimization in MS: Canadian MS Working Group updated recommendations.

Authors:  Mark S Freedman; Daniel Selchen; Douglas L Arnold; Alexandre Prat; Brenda Banwell; Michael Yeung; David Morgenthau; Yves Lapierre
Journal:  Can J Neurol Sci       Date:  2013-05       Impact factor: 2.104

9.  Clinical relevance using timed walk tests and 'timed up and go' testing in persons with multiple sclerosis.

Authors:  Ylva Nilsagard; Cecilia Lundholm; Lars-Gunnar Gunnarsson; Eva Dcnison
Journal:  Physiother Res Int       Date:  2007-06

10.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

View more
  13 in total

Review 1.  Next Steps in Wearable Technology and Community Ambulation in Multiple Sclerosis.

Authors:  Mikaela L Frechette; Brett M Meyer; Lindsey J Tulipani; Reed D Gurchiek; Ryan S McGinnis; Jacob J Sosnoff
Journal:  Curr Neurol Neurosci Rep       Date:  2019-09-04       Impact factor: 5.081

2.  Six-minute walk test is reliable and sensitive in detecting response to therapy in CIDP.

Authors:  Emanuele Spina; Antonietta Topa; Rosa Iodice; Stefano Tozza; Lucia Ruggiero; Raffaele Dubbioso; Marcello Esposito; Pasquale Dolce; Lucio Santoro; Fiore Manganelli
Journal:  J Neurol       Date:  2019-02-05       Impact factor: 4.849

Review 3.  An Update on the Measurement of Motor Cerebellar Dysfunction in Multiple Sclerosis.

Authors:  Katherine Hope Kenyon; Frederique Boonstra; Gustavo Noffs; Helmut Butzkueven; Adam P Vogel; Scott Kolbe; Anneke van der Walt
Journal:  Cerebellum       Date:  2022-06-27       Impact factor: 3.648

4.  Metabolic and Functional Improvements in a Patient with Charcot-Marie-Tooth Disease Type 2 after EGCG Administration: A Case Report.

Authors:  Antonio Bustos; Pablo Selvi Sabater; María Benlloch; Eraci Drehmer; María Mar López-Rodríguez; Felix Platero; Jose Luis Platero; Jesús Escribá-Alepuz; Jose Enrique de la Rubia Ortí
Journal:  Medicina (Kaunas)       Date:  2021-01-24       Impact factor: 2.430

5.  The Two-Minute Walk Test in Persons with Multiple Sclerosis: Correlations of Cadence with Free-Living Walking Do Not Support Ecological Validity.

Authors:  Viktoria Karle; Verena Hartung; Keti Ivanovska; Mathias Mäurer; Peter Flachenecker; Klaus Pfeifer; Alexander Tallner
Journal:  Int J Environ Res Public Health       Date:  2020-12-04       Impact factor: 3.390

6.  A Two-Minute Walking Test With a Smartphone App for Persons With Multiple Sclerosis: Validation Study.

Authors:  Pim van Oirschot; Marco Heerings; Karine Wendrich; Bram den Teuling; Frank Dorssers; René van Ee; Marijn Bart Martens; Peter Joseph Jongen
Journal:  JMIR Form Res       Date:  2021-11-17

7.  Is the dynamic gait index a useful outcome to measure balance and ambulation in patients with cerebellar ataxia?

Authors:  Rachel Reoli; Amanda Therrien; Kendra Cherry-Allen; Jennifer Keller; Jennifer Millar; Amy Bastian
Journal:  Gait Posture       Date:  2021-07-21       Impact factor: 2.746

8.  Vestibular rehabilitation in multiple sclerosis: study protocol for a randomised controlled trial and cost-effectiveness analysis comparing customised with booklet based vestibular rehabilitation for vestibulopathy and a 12 month observational cohort study of the symptom reduction and recurrence rate following treatment for benign paroxysmal positional vertigo.

Authors:  J Marsden; M Pavlou; R Dennett; A Gibbon; R Knight-Lozano; L Jeu; C Flavell; J Freeman; D E Bamiou; C Harris; A Hawton; E Goodwin; B Jones; S Creanor
Journal:  BMC Neurol       Date:  2020-11-27       Impact factor: 2.474

9.  Siponimod: A Review in Secondary Progressive Multiple Sclerosis.

Authors:  Lesley J Scott
Journal:  CNS Drugs       Date:  2020-10-27       Impact factor: 5.749

Review 10.  Outcome measures assisting treatment optimization in multiple sclerosis.

Authors:  Gabriel Pardo; Samantha Coates; Darin T Okuda
Journal:  J Neurol       Date:  2021-08-02       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.